Legend Total Liab vs Total Current Liabilities Analysis
LEGN Stock | USD 44.38 1.41 3.28% |
Legend BiotechCorp financial indicator trend analysis is infinitely more than just investigating Legend BiotechCorp recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Legend BiotechCorp is a good investment. Please check the relationship between Legend BiotechCorp Total Liab and its Total Current Liabilities accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Legend BiotechCorp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide.
Total Liab vs Total Current Liabilities
Total Liab vs Total Current Liabilities Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Legend BiotechCorp Total Liab account and Total Current Liabilities. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Legend BiotechCorp's Total Liab and Total Current Liabilities is 0.98. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of Legend BiotechCorp, assuming nothing else is changed. The correlation between historical values of Legend BiotechCorp's Total Liab and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of Legend BiotechCorp are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Total Liab i.e., Legend BiotechCorp's Total Liab and Total Current Liabilities go up and down completely randomly.
Correlation Coefficient | 0.98 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Total Liab
The total amount of all liabilities that a company has, including both short-term and long-term liabilities.Total Current Liabilities
Total Current Liabilities is an item on Legend BiotechCorp balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Legend BiotechCorp are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most indicators from Legend BiotechCorp's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Legend BiotechCorp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Legend BiotechCorp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide.As of the 14th of May 2024, Selling General Administrative is likely to grow to about 112.1 M, while Tax Provision is likely to drop about 268.9 K.
2021 | 2022 | 2023 | 2024 (projected) | Other Operating Expenses | 462.8M | 575.1M | 727.4M | 365.7M | Total Revenue | 89.8M | 117.0M | 285.1M | 299.4M |
Legend BiotechCorp fundamental ratios Correlations
Click cells to compare fundamentals
Legend BiotechCorp Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Legend BiotechCorp fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 287.7M | 721.0M | 1.1B | 1.3B | 1.8B | 938.8M | |
Other Current Liab | 70.9M | 99.2M | 211.4M | 260.9M | 140.1M | 147.9M | |
Total Current Liabilities | 127.8M | 161.2M | 280.3M | 297.8M | 216.4M | 203.5M | |
Total Stockholder Equity | (122.9M) | 280.3M | 471.2M | 744.3M | 1.3B | 1.3B | |
Other Liab | 277.8M | 277.7M | 244.8M | 7.9M | 7.1M | 6.7M | |
Net Tangible Assets | (123.4M) | 277.4M | 466.5M | 740.9M | 852.0M | 894.6M | |
Retained Earnings | (127.3M) | (430.8M) | (817.0M) | (966.5M) | (1.5B) | (1.4B) | |
Accounts Payable | 9.6M | 5.2M | 7.0M | 32.9M | 20.2M | 13.6M | |
Cash | 83.4M | 455.7M | 688.9M | 786.0M | 1.3B | 1.3B | |
Other Assets | 665K | 4.2M | 7.3M | 67.7M | 1.0 | 0.95 | |
Cash And Short Term Investments | 158.9M | 505.7M | 882.4M | 1.0B | 1.3B | 1.4B | |
Net Receivables | 35.8M | 85.0M | 63.2M | 90K | 157.1M | 164.9M | |
Inventory | 1.2M | 1.8M | 1.7M | 10.4M | 19.4M | 20.4M | |
Other Stockholder Equity | 3.9M | 430.8M | 817.0M | 744.3M | 2.6B | 2.8B | |
Total Liab | 410.6M | 440.8M | 647.2M | 586.7M | 589.9M | 522.0M | |
Total Current Assets | 207.1M | 592.9M | 948.8M | 1.1B | 1.5B | 770.5M | |
Intangible Assets | 5.1M | 7.7M | 4.7M | 3.4M | 155.3M | 163.0M | |
Property Plant Equipment | 79.4M | 121.1M | 152.9M | 160.8M | 184.9M | 100.7M | |
Short Long Term Debt Total | 6.1M | 3.4M | 123.0M | 284.5M | 328.7M | 345.1M | |
Property Plant And Equipment Net | 75.5M | 121.3M | 155.1M | 161.7M | 189.7M | 135.0M | |
Current Deferred Revenue | 46.3M | 55.3M | 60.9M | 451K | 53.0M | 34.2M | |
Net Debt | (77.3M) | (452.3M) | (566.0M) | (501.5M) | (949.4M) | (901.9M) | |
Non Current Assets Total | 80.6M | 128.1M | 169.6M | 231.8M | 350.8M | 194.9M | |
Non Currrent Assets Other | 665K | 4.0M | 5.1M | 66.8M | 152.4M | 160.0M | |
Common Stock Shares Outstanding | 132.0M | 118.2M | 140.9M | 159.0M | 176.1M | 151.5M | |
Short Term Investments | 75.6M | 50M | 193.5M | 239.6M | 31.0M | 29.5M | |
Liabilities And Stockholders Equity | 287.7M | 721.0M | 1.1B | 1.3B | 1.8B | 1.1B | |
Non Current Liabilities Total | 282.8M | 279.6M | 366.9M | 288.9M | 373.5M | 339.7M | |
Capital Lease Obligations | 6.1M | 3.4M | 2.5M | 23.6M | 47.3M | 49.7M | |
Other Current Assets | 11.3M | 580.7M | 1.4M | 1.1B | 12.2M | 11.6M | |
Net Invested Capital | (122.9M) | 280.3M | 591.7M | 1.0B | 1.5B | 1.6B | |
Property Plant And Equipment Gross | 74.8M | 116.5M | 155.1M | 161.7M | 224.7M | 140.2M | |
Accumulated Other Comprehensive Income | (122.9M) | 280.2M | 471.2M | 744.3M | 98.9M | 94.0M | |
Net Working Capital | 79.3M | 431.7M | 668.5M | 801.3M | 1.3B | 1.3B | |
Short Term Debt | 1.0M | 1.5M | 911K | 3.6M | 3.2M | 1.9M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Legend BiotechCorp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide.Note that the Legend BiotechCorp information on this page should be used as a complementary analysis to other Legend BiotechCorp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for Legend Stock analysis
When running Legend BiotechCorp's price analysis, check to measure Legend BiotechCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Legend BiotechCorp is operating at the current time. Most of Legend BiotechCorp's value examination focuses on studying past and present price action to predict the probability of Legend BiotechCorp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Legend BiotechCorp's price. Additionally, you may evaluate how the addition of Legend BiotechCorp to your portfolios can decrease your overall portfolio volatility.
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Commodity Directory Find actively traded commodities issued by global exchanges |
Is Legend BiotechCorp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend BiotechCorp. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend BiotechCorp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.94) | Revenue Per Share 1.619 | Quarterly Revenue Growth 1.876 | Return On Assets (0.17) | Return On Equity (0.52) |
The market value of Legend BiotechCorp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend BiotechCorp's value that differs from its market value or its book value, called intrinsic value, which is Legend BiotechCorp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend BiotechCorp's market value can be influenced by many factors that don't directly affect Legend BiotechCorp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend BiotechCorp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend BiotechCorp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend BiotechCorp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.